FDA Public Workshop on Clinical
Trial Endpoints in Prostate Cancer
The Food and Drug Administration (FDA) is
holding a public workshop on endpoints for prostate cancer. Issues
identified in the workshop will be further discussed before the
Oncologic Drugs Advisory Committee (ODAC) and thereafter will be
detailed in FDA Guidance Documents.
Date:
June 21-22, 2004, from 8:00 a.m. to 5:00
p.m.
Address:
Bethesda Marriott,
5151 Pooks Hill Road,
Bethesda, MD 20814, (301) 897-9400
Metro
Access: Closest Metro stop is Medical Center
on the RED line. Shuttle Service provided by the Bethesda Marriott from the Medical
Center Metro stop approximately every hour and half hour between
6:30 am - 10:30 am and 3:30 pm - 8:30 pm. Outside these times, there is
a taxi stand available at the Bethesda Metro stop.
Registration:
No registration is required to attend the
meeting. Seating will be available for 300 people on a first-come,
first-served basis.
For further information, contact:
Dianne Spillman, Division of Oncology
Drug Products (HFD-150), Center for Drug Evaluation and Research,
Food and Drug Administration, 5600 Fishers Lane, Rockville, MD
20857. Phone: 301-594-5746. Email:
spillmand@cder.fda.gov
Back
to Top
Back to Cancer Endpoints
Date created: April 9, 2004 |